Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration
Citations Over TimeTop 1% of 2014 papers
Abstract
To realize cardiac regeneration using human induced pluripotent stem cells (hiPSCs), strategies for cell preparation, tissue engineering and transplantation must be explored. Here we report a new protocol for the simultaneous induction of cardiomyocytes (CMs) and vascular cells [endothelial cells (ECs)/vascular mural cells (MCs)], and generate entirely hiPSC-engineered cardiovascular cell sheets, which showed advantageous therapeutic effects in infarcted hearts. The protocol adds to a previous differentiation protocol of CMs by using stage-specific supplementation of vascular endothelial cell growth factor for the additional induction of vascular cells. Using this cell sheet technology, we successfully generated physically integrated cardiac tissue sheets (hiPSC-CTSs). HiPSC-CTS transplantation to rat infarcted hearts significantly improved cardiac function. In addition to neovascularization, we confirmed that engrafted human cells mainly consisted of CMs in >40% of transplanted rats four weeks after transplantation. Thus, our HiPSC-CTSs show promise for cardiac regenerative therapy.
Related Papers
- → Induced pluripotent stem cells for cardiac repair(2012)42 cited
- → Perspectives of induced pluripotent stem cells for cardiovascular system regeneration(2015)22 cited
- → Induced Pluripotent Stem Cells and Their Use in Cardiac and Neural Regenerative Medicine(2015)18 cited
- → Induced Pluripotent Stem Cells in Regenerative Medicine and Disease Modeling(2014)18 cited
- → Human Pluripotent Cells for Regenerative Medicine: Potential Applications for Regenerative Medicine(2010)